Meanwhile, Song and colleagues revealed that TREML2 rs3747742‐C was related to a reduced CSF total tau level in AD patients after controlling for age, gender, education, and APOE ε4 status (Song et al., 2019). This evidence concerns the gene TREML2 and Alzheimer disease.